Choreo, LLC Connect Biopharma Holdings LTD Transaction History
Choreo, LLC
- $6.88 Billion
- Q4 2024
A detailed history of Choreo, LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Choreo, LLC holds 160,867 shares of CNTB stock, worth $133,519. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160,867Holding current value
$133,519% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CNTB
# of Institutions
17Shares Held
3.28MCall Options Held
14KPut Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$1.74 Million1.79% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$423,8810.04% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny135KShares$111,7980.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$86,2290.0% of portfolio
-
Royal Bank Of Canada Toronto, A680.4KShares$66,7320.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $45.7M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...